These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10539871)

  • 1. Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues.
    Grayston JT; Jackson LA; Kennedy WJ; Kronmal RA
    Am Heart J; 1999 Nov; 138(5 Pt 2):S545-9. PubMed ID: 10539871
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease.
    Gupta S
    Am Heart J; 1999 Nov; 138(5 Pt 2):S539-41. PubMed ID: 10539869
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlamydia pneumoniae in coronary artery disease.
    Gurfinkel E; Bozovich G; Mautner B; Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 2000 Mar; 101(12):E118-9. PubMed ID: 10736300
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics in the prevention of heart attacks.
    Danesh J
    Lancet; 2005 Jan 29-Feb 4; 365(9457):365-7. PubMed ID: 15680439
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic treatment trials for secondary prevention of coronary artery disease events.
    Grayston JT
    Circulation; 1999 Mar; 99(12):1538-9. PubMed ID: 10096927
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis.
    Grayston JT
    Am Heart J; 1999 Nov; 138(5 Pt 2):S556-7. PubMed ID: 10539875
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease.
    Behbahani R; Verme-Gibboney C; Romanelli AM
    Clin Ther; 1999 Aug; 21(8):1286-300; discussion 1285. PubMed ID: 10485501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides?
    Shafran SD; Conley JM
    Can J Cardiol; 1997 Nov; 13(11):1017-9. PubMed ID: 9413231
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention antibiotic treatment trials for coronary artery disease.
    Grayston JT
    Circulation; 2000 Oct; 102(15):1742-3. PubMed ID: 11023925
    [No Abstract]   [Full Text] [Related]  

  • 11. Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.
    Rosen H; Muhlestein JB; Bartlett J; Chen S; Chikami G; Corson M; Shah PK; Gurfinkel E; Handsfield H; Jackson L; Knirsch C; Kronmal R; McCutchan JA; Shea S
    J Infect Dis; 2000 Jun; 181 Suppl 3():S582-4. PubMed ID: 10839764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?].
    Møller K; Skinhøj P
    Ugeskr Laeger; 1999 Sep; 161(37):5173-4. PubMed ID: 10523951
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae.
    Gupta S; Camm AJ
    Clin Cardiol; 1997 Oct; 20(10):829-36. PubMed ID: 9377818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment of atherosclerotic cardiovascular disease.
    Grayston JT
    Circulation; 2003 Mar; 107(9):1228-30. PubMed ID: 12628937
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chlamydia pneumoniae: an agent involved in the pathogenesis of asthma].
    Perpiñá Tordera M; de Diego Damiá A
    Rev Clin Esp; 1998 Sep; 198 Suppl 1():24-9. PubMed ID: 9835770
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective.
    Gurfinkel E
    J Infect Dis; 2000 Jun; 181 Suppl 3():S566-8. PubMed ID: 10839760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chlamydia pneumoniae and arteriosclerosis: an innocent onlooker?].
    Vidal Verdú E
    An Med Interna; 1999 Jul; 16(7):329-32. PubMed ID: 10481330
    [No Abstract]   [Full Text] [Related]  

  • 20. Animal models of chlamydia and atherosclerosis.
    Muhlestein JB
    Am Heart J; 1999 Nov; 138(5 Pt 2):S514-5. PubMed ID: 10539862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.